Powered by: Motilal Oswal
2025-10-11 09:48:29 am | Source: Choice Broking Ltd
Sell Tata Elxsi Ltd for the Target Rs.4,120 by Choice Broking Ltd
Sell Tata Elxsi Ltd for the Target Rs.4,120 by Choice Broking Ltd

In-Line Q2 Performance; H2FY26 Growth Visibility Improves

TELX reported an in-line performance for Q2FY26 with modest sequential recovery and early signs of operational stabilisation. While near-term challenges persist in Automotive and Media & Communications, H2FY26 growth visibility has improved on the back of large Transportation deal ramp-ups and a strong Healthcare pipeline. Margins are expected to recover gradually with higher utilization and operational efficiencies. We maintain our PE multiple at 28x, arriving at a Target Price of INR 4,120 based on average FY27E–FY28E EPS of 147.3. We reiterate our SELL rating, while noting that sustained doubledigit growth momentum in the Transportation & HLS vertical, margin expansion, and improved deal wins in Media & Communications could act as potential re-rating triggers.

Q2FY26 Revenue & PAT in-line; EBITM Modestly above our Estimates

* Revenue for Q2FY26 came in at INR 9.1Bn, up 1.0% QoQ but down 8.3% YoY in CC. In INR terms, revenue rose 2.9% QoQ but declined 3.9% YoY (vs CIE est. at INR 9.1Bn).

* EBIT for Q2FY26 came in at INR 1.7Bn, up 4.6% QoQ but down 29.0% YoY (vs CIE est. at INR 1.6Bn). EBIT margin was up 29bps QoQ but down 655bps YoY to 18.5% (vs CIE est. at 18.1%).

* PAT for Q2FY26 stood at INR 1.5Bn, up 7.2% QoQ but down 32.5% YoY (vs CIE est. at INR 1.5Bn).

Muted Quarter; Revenue Growth Driven by Transportation & HLS: TELX reported a soft Q2FY26, with sequential revenue growth of 1.0% in CC, marking a modest recovery after 2 consecutive quarters of decline. Growth was led by Media & Communications segment (+4% QoQ), partially offset by moderate gains in Transportation and a 4.5% QoQ decline in Healthcare and Lifescience (HLS). Transportation was impacted by the deferment of a JLR program due to cybersecurity concerns, though traction across other SDV programs, global OEMs, and Aerospace & Defence sub-segments supports expectations of double-digit growth in FY27E. HLS de-growth reflects completed regulatory programs, but a strong pipeline underpins similar FY27E growth expectations. Media & Communications remains subdued amid industry restructuring, though selective deal ramp-ups provide limited near-term support. We believe near-term growth remains moderate, with H2FY26 expected to post stronger sequential performance, led by large-deal ramp-ups and improvement in utilization.

Sequential Margin Recovery, Utilization Levers to Drive FY27E Growth: TELX reported EBITM of 18.5% in Q2FY26, up 30bps QoQ, aided by favourable currency movement and higher utilization, partially offset by increased people and AI infrastructure costs. Utilization improved to 70% (vs. 66% in Q1), with management targeting 75% by FY26-end, supporting gradual margin recovery despite upcoming Q3 wage hike. We expect FY26 EBITM to stabilise at 18.9% (vs. 23.3% in FY25), with a return to the 22–23% band in FY27E dependent on sustained revenue growth and operational execution. We maintain a constructive medium-term view, given the company’s strong cost discipline, improving utilization trajectory and leverage potential from large deal rampups in Transportation and Healthcare

 

For Detailed Report With Disclaimer Visit. https://choicebroking.in/disclaimer

SEBI Registration no.: INZ 000160131

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here